# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3748105 | B | Induction of bovine LPL stabilization using intralipid as substrate at 3.12 uM preincubated for 10 mins with human recombinant ANGPTL4 followed by substrate addition measured after 45 mins relative to control | Bos taurus | 61 | ALA3745639 | single protein format | Scientific Literature | |
2. | ALA3748106 | B | Induction of bovine LPL stabilization using intralipid as substrate at 6.25 uM preincubated for 10 mins with human recombinant ANGPTL4 followed by substrate addition measured after 45 mins relative to control | Bos taurus | 61 | ALA3745639 | single protein format | Scientific Literature | |
3. | ALA3748107 | B | Induction of bovine LPL stabilization using intralipid as substrate at 12.5 uM preincubated for 10 mins with human recombinant ANGPTL4 followed by substrate addition measured after 45 mins relative to control | Bos taurus | 61 | ALA3745639 | single protein format | Scientific Literature | |
4. | ALA3748108 | B | Induction of bovine LPL stabilization using intralipid as substrate at 25 uM preincubated for 10 mins with human recombinant ANGPTL4 followed by substrate addition measured after 45 mins relative to control | Bos taurus | 61 | ALA3745639 | single protein format | Scientific Literature | |
5. | ALA3748113 | A | Drug level in human plasma treated with 1,3-Dioxo-2-(4-(piperidin-1-yl)-3-(p-tolylcarbamoyl)phenyl)isoindoline-5-carboxylic acid at 10 uM after 24 hrs by LC-MS/MS analysis | Homo sapiens | 3 | ALA3745639 | cell-free format | Scientific Literature |